CJC-1295 with DAC

CJC-1295 DAC · Drug Affinity Complex

A GHRH analog bound to a drug affinity complex, extending its half-life to several days and allowing weekly dosing.

Research use only. This compound is sold for laboratory research and is not approved by the FDA for human use. Everything below is reference information about what circulating protocols state — not a recommendation to use it.

At a glance

Category: Growth Hormone
Half-life: ~7 days
Typical vial sizes: 2 mg · 5 mg
Commonly cited dose: 1000–2000 mcg
Frequency: once or twice weekly
Routes: Subcutaneous

A 2 mg vial, worked through.

Reconstituting a 2 mg vial of CJC-1295 with DAC with 2 mL of bacteriostatic water gives 1 mg/mL. A 1000 mcg dose is then:

100units(1 mL) — about 2 doses per vial

Storage

Lyophilised (unmixed): Refrigerated, protected from light.
Reconstituted: Refrigerate at 2–8°C.

What people log it against

Outcomes users commonly track alongside this compound. Listing them is not a claim that it produces them.

Sustained growth hormone support

References

The figures on this page have not yet been verified against primary literature. Treat them as provisional and confirm against a primary source before relying on them.

Run your own numbers

Pick CJC-1295 with DAC from the preset list to start from a typical vial.

Your vial

Peptide in vial

As printed on the vial label

Bacteriostatic water added

How much you inject into the vial

Dose you want

mcg

1000 mcg = 1 mg

Syringe size

Start from a peptide

Fills in a common vial size and the low end of commonly cited protocols. Always check against your own vial.

Draw this much

5units

on a 1 mL U-100 insulin syringe

Concentration: 5 mg/mL
Volume: 0.05 mL
Doses in this vial: 40